Skip to content
The GLP-1 Verdict
Menu
Ranked #229 · Grade C

Belle Health review

Nine-year-old Utah telehealth firm offering compounded and brand GLP-1s in all fifty states, carrying an FDA warning letter from February 2026.

Belle Health — FDA warning letter, February 2026. Addressed to Belle Health LLC dba Belle, and public in FDA’s warning-letter database.

Visit Belle Health Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $119/mo (compounded)
Tirzepatide
From $175/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

The scorecard

Belle Health scored on our six published factors. See the methodology.

Real-world results65/100
Price honesty60/100
Prescriber access75/100
Formulary choice85/100
Cancellation fairness50/100
Member support70/100

What we like

  • Offers brand Wegovy (from $1,400/mo) and brand Zepbound (from $1,999/mo) alongside the compounded lines, so a switch to an FDA-approved product does not mean changing provider
  • Compounded prices are published before intake: from $119 a month for semaglutide and from $175 a month for tirzepatide
  • Weekly registered-dietitian sessions are included in the monthly price at no extra charge
  • Trading since 2017, which is unusually long for this segment
  • The site states plainly that 'Compounded medications are not evaluated or approved by the FDA' rather than burying the caveat

The caveats

  • FDA issued a warning letter to Belle Health LLC dba Belle in February 2026; it is public in FDA's warning-letter database
  • Compounded semaglutide and tirzepatide are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality
  • Both compounded prices are 'from' prices, so the figure you are quoted after intake may be higher than the one advertised
  • The pharmacy partners named in the Terms have been swapped out entirely, and two of the current four have publicly stepped back from GLP-1 compounding
  • No refunds on prescription or compounded products once shipped, and no telephone support is published

The verdict

Best for: Someone who wants a compounded starting price at the low end of the market with the option to switch to brand Wegovy or Zepbound on the same account. Nine-year-old Utah telehealth firm offering compounded and brand GLP-1s in all fifty states, carrying an FDA warning letter from February 2026.

Ranked #229 of 539 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. In the ranking it sits between System Labs at #228, 65/100 above and Bayan Health at #230, 67/100 below, with the ARSYNL Rx ruling the next one down.

If that ruling leaves you undecided, the 7 programs we rank against Belle Health are graded on the same six factors and listed in score order.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Belle Health goes to CoreAge Rx, 94/100 to 67/100.

Compare with other providers

The closest rulings to Belle Health by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect Belle Health's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Belle Health's site. Not medical advice; see our disclosure.

← Back to all rankings